Viral innate immunity in S. cerevisiae

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:0 publications

Grant number: 469976

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2022
  • Known Financial Commitments (USD)

    $574,735.47
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    Meneghini Marc D
  • Research Location

    Canada
  • Lead Research Institution

    University of Toronto
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Disease models

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Viruses infect all known forms of life, including single celled organisms such as bacteria and yeasts. While studies of viruses in bacteria have led to remarkable advances for basic research such as the discovery of CRISPR, single-celled eukaryotic organisms have been comparatively silent on this topic. We have discovered a new anti-viral mechanism in the budding yeast Saccharomyces cerevisiae. This mechanism employs a protein called Nuc1, which is homologous to endonuclease G (endoG), a protein family found in all eukaryotic organisms, and even in bacteria. Nuc1, like endoG, resides within the cells mitochondria, a known hub of viral innate immunity in humans. Through our studies of Nuc1, we have discovered that the yeast "L-A" virus causes lethal pathogenesis when it is left unchecked in cells lacking Nuc1. We have exploited this lethal consequence of the L-A virus to discover new factors controlling viral repression. Intriguingly, human homologs of some of these factors attenuate SARS-Cov-2, though their mechanism remains unknown. This work exploits the unparalleled power of yeast as an experimental model to investigate these new viral repression mechanisms.